Chemotherapy Induced Nausea and Vomiting Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
Chemotherapy Induced Nausea and Vomiting Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global chemotherapy induced nausea and vomiting drugs market is expected to grow at a CAGR of around 5.4% during 2025-2034. This report on global chemotherapy induced nausea and vomiting drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global chemotherapy induced nausea and vomiting drugs market by segmenting the market based on form, drug class, patient pool type, emetogenic risk, distribution channel and region. Also, detailed profiles of companies operating in the chemotherapy induced nausea and vomiting drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Prevalence of Cancer • High Investments
Market Challenges
• High Costs
Historical & Forecast Period
Base Year: 2024 Historical Period: 2020-2024 Forecast Period: 2025-2034
• CINV Hospitals • Cancer Research Institute • Retail Pharmacies • Online Pharmacies • Drug Stores
Market by Region
• Europe Germany United Kingdom France Italy Spain Russia Netherlands Rest of Europe • North America United States Canada • Asia Pacific China Japan India South Korea Australia Indonesia Rest of Asia Pacific • Latin America Mexico Brazil Argentina Rest of Latin America • Middle East & Africa Saudi Arabia Turkey Iran United Arab Emirates Rest of Middle East & Africa
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Chemotherapy Induced Nausea and Vomiting Drugs Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Chemotherapy Induced Nausea and Vomiting Drugs Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Form
5.1. Introduction
5.2. Injectables
5.3. Oral
5.4. Transdermal Patches
6. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Drug Class
6.1. Introduction
6.2. 5-HT3 Receptor Antagonists
6.3. Neurokinin-1 Receptor Antagonists
6.4. Corticosteroids
6.5. Cannabinoids
7. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Patient Pool Type
7.1. Introduction
7.2. Aloxi
7.3. Kytril Generic
7.4. Emend
7.5. Netupitant-Palonosetron
7.6. Others
8. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Emetogenic Risk
8.1. Introduction
8.2. Highly Emetogenic Chemotherapy (HEC)
8.3. Moderately Emetogenic Chemotherapy (MEC)
8.4. Low Emetogenic Chemotherapy (LEC)
9. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Distribution Channel
9.1. Introduction
9.2. CINV Hospitals
9.3. Cancer Research Institute
9.4. Retail Pharmacies
9.5. Online Pharmacies
9.6. Drug Stores
10. Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Region
10.1. Introduction
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Netherlands
10.2.8. Rest of the Europe
10.3. North America
10.3.1. United States
10.3.2. Canada
10.4. Asia Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. South Korea
10.4.5. Australia
10.4.6. Indonesia
10.4.7. Rest of the Asia Pacific
10.5. Latin America
10.5.1. Mexico
10.5.2. Brazil
10.5.3. Argentina
10.5.4. Rest of Latin America
10.6. Middle East & Africa
10.6.1. Saudi Arabia
10.6.2. Turkey
10.6.3. Iran
10.6.4. United Arab Emirates
10.6.5. Rest of Middle East & Africa
11. SWOT Analysis
12. Porter’s Five Forces
13. Market Value Chain Analysis
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Company Profiles
14.2.1. Acacia Pharma
14.2.2. Amneal Pharmaceuticals
14.2.3. Baxter
14.2.4. Cadila Pharmaceuticals Limited
14.2.5. GlaxoSmithKline plc
14.2.6. Helsinn Holding S.A.
14.2.7. Heron Therapeutics, Inc.
14.2.8. Insys Therapeutics, Inc
14.2.9. Kyowa Kirin, Inc.
14.2.10. Merck & Co., Inc
14.2.11. Novartis AG
14.2.12. Orchid Healthcare
14.2.13. Sun Pharmaceutical Industries Ltd.
14.2.14. Tesaro, Inc.
List of Figures
Figure 1: Global Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 2: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Form, 2024
Figure 3: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Drug Class, 2024
Figure 4: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Patient Pool Type, 2024
Figure 5: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Emetogenic Risk, 2024
Figure 6: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Distribution Channel, 2024
Figure 7: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Region, 2024
Figure 8: Global Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 9: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Form (in %), 2024 & 2034
Figure 10: Global Injectables Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 11: Global Injectables Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 12: Global Oral Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 13: Global Oral Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 14: Global Transdermal Patches Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 15: Global Transdermal Patches Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 16: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Drug Class (in %), 2024 & 2034
Figure 17: Global 5-HT3 Receptor Antagonists Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 18: Global 5-HT3 Receptor Antagonists Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 19: Global Neurokinin-1 Receptor Antagonists Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 20: Global Neurokinin-1 Receptor Antagonists Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 21: Global Corticosteroids Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 22: Global Corticosteroids Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 23: Global Cannabinoids Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 24: Global Cannabinoids Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 25: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Patient Pool Type (in %), 2024 & 2034
Figure 26: Global Aloxi Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 27: Global Aloxi Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 28: Global Kytril Generic Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 29: Global Kytril Generic Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 30: Global Emend Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 31: Global Emend Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 32: Global Netupitant-Palonosetron Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 33: Global Netupitant-Palonosetron Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 34: Global Other Pool Types Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 35: Global Other Pool Types Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 36: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Emetogenic Risk (in %), 2024 & 2034
Figure 37: Global Highly Emetogenic Chemotherapy (HEC) Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 38: Global Highly Emetogenic Chemotherapy (HEC) Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 39: Global Moderately Emetogenic Chemotherapy (MEC) Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 40: Global Moderately Emetogenic Chemotherapy (MEC) Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 41: Global Low Emetogenic Chemotherapy (LEC) Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 42: Global Low Emetogenic Chemotherapy (LEC) Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 43: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Distribution Channel (in %), 2024 & 2034
Figure 44: Global CINV Hospitals Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 45: Global CINV Hospitals Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 46: Global Cancer Research Institute Generic Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 47: Global Cancer Research Institute Generic Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 48: Global Retail Pharmacies Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 49: Global Retail Pharmacies Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 50: Global Online Pharmacies Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 51: Global Online Pharmacies Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 52: Global Drug Stores Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 53: Global Drug Stores Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 54: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Region (in %), 2024 & 2034
Figure 55: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Region (in %), 2024 & 2034
Figure 56: Europe Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 57: Europe Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 58: Europe Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in %), 2024 & 2034
Figure 59: Germany Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 60: United Kingdom Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 61: France Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 62: Italy Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 63: Spain Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 64: Russia Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 65: Netherlands Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 66: North America Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 67: North America Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 68: North America Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in %), 2024 & 2034
Figure 69: United States Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 70: Canada Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 71: Asia Pacific Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 72: Asia Pacific Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 73: Asia Pacific Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in %), 2024 & 2034
Figure 74: China Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 75: Japan Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 76: India Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 77: South Korea Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 78: Australia Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 79: Indonesia Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 80: Latin America Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 81: Latin America Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 82: Latin America Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in %), 2024 & 2034
Figure 83: Mexico Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 84: Brazil Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 85: Argentina Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 86: Middle East & Africa Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2020-2024
Figure 87: Middle East & Africa Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2025-2034
Figure 88: Middle East & Africa Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in %), 2024 & 2034
Figure 89: Saudi Arabia Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 90: Turkey Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 91: Iran Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 92: UAE Chemotherapy Induced Nausea and Vomiting Drugs Market (in US$ Million), 2018-2030
Figure 93: Market Value Chain
List of Tables
Table 1: Global Chemotherapy Induced Nausea and Vomiting Drugs Market Portraiture
Table 2: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Form (in US$ Million), 2024 & 2034
Table 3: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Drug Class (in US$ Million), 2024 & 2034
Table 4: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Patient Pool Type (in US$ Million), 2024 & 2034
Table 5: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Emetogenic Risk (in US$ Million), 2024 & 2034
Table 6: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 7: Global Chemotherapy Induced Nausea and Vomiting Drugs Market by Region (in US$ Million), 2024 & 2034
Table 8: Europe Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in US$ Million), 2024 & 2034
Table 9: North America Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in US$ Million), 2024 & 2034
Table 10: Asia Pacific Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in US$ Million), 2024 & 2034
Table 11: Latin America Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in US$ Million), 2024 & 2034
Table 12: Middle East & Africa Chemotherapy Induced Nausea and Vomiting Drugs Market by Country (in US$ Million), 2024 & 2034